Nitroxoline, identified by its CAS number 4008-48-4, is a compound of significant interest within the chemical and pharmaceutical industries due to its versatile applications. While widely recognized for its antibacterial properties, its utility extends to its role as a key pharmaceutical intermediate and its emerging potential in anticancer research. NINGBO INNO PHARMCHEM CO.,LTD. plays a vital role in supplying high-quality Nitroxoline to facilitate these advancements.

As a pharmaceutical intermediate, Nitroxoline serves as a crucial building block in the synthesis of more complex drug molecules. Its quinoline structure and reactive functional groups allow for chemical modifications, leading to the development of new therapeutic agents. The compound's inherent biological activity also makes it an attractive starting point for creating derivatives with enhanced or specialized properties, supporting innovation in drug discovery.

The antibacterial efficacy of Nitroxoline remains a primary area of application. It has proven effective against a range of Gram-negative bacteria, including those that exhibit resistance to common antibiotics. This makes it a valuable asset in the ongoing effort to combat antimicrobial resistance. Its ability to disrupt bacterial biofilms further enhances its utility in treating persistent and difficult-to-eradicate infections.

Furthermore, recent research is highlighting Nitroxoline's potential in oncology. Studies suggest that it possesses antiproliferative effects on cancer cells and can influence tumor growth pathways, positioning it as a candidate for drug repurposing in cancer treatment. This dual action—antibacterial and anticancer—underscores the compound's broad therapeutic relevance.

For chemical and pharmaceutical companies, sourcing reliable Nitroxoline is paramount for successful research and product development. NINGBO INNO PHARMCHEM CO.,LTD. is committed to providing high-purity Nitroxoline, ensuring consistency and quality for its clients. By supplying this essential chemical, the company supports critical research into new antibacterial strategies, novel anticancer therapies, and the development of advanced pharmaceutical intermediates.

The multifaceted nature of Nitroxoline ensures its continued importance in scientific and industrial applications, driving innovation and contributing to solutions for significant health challenges.